PharmGKB lists no pharmacogenomic annotations requiring dose adjustment for tirzepatide based on genotype or ancestry as of early 2026
Gastrointestinal problems such as nausea were the most common side effects, which totaled 25.5% of all adverse events in the liraglutide group
On the other hand, processes specific to the secondary network involved 30 genes related to the Parkin-Ubiquitin Proteasomal System pathway (PSMD10, PSMD12, PSMD11, PSMD14, TUBAL3, HSPA1L, PSMD13, HSPA6, UBE2J2, HSPA14, PSMD8, PSMD7, PSMD4, PSMC3, PSMC4, PSMC1, PSMD3, PSMC2, PSMD1, UBA1), Striated Muscle Contraction Pathway, genes associated with Genome Maintenance, oxidative stress, and hypoxia-related terms (Fig
Those apply regardless of source
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review
Semaglutide stands out among GLP-1 agonists for its unique features and remarkable benefits